International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Spiros Miyakis, Steven A. Krilis, Anǵela Tincani et al.|Journal of Thrombosis and Haemostasis|2006Cited by 7.1k
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control studyRolf T. Urbanus, Ale Algra, Bob Siegerink et al.|The Lancet Neurology|2009Cited by 428
Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1Mirjam E. Meltzer, Frits R. Rosendaal, Ton Lisman et al.|Blood|2010Cited by 363
Reduced plasma fibrinolytic potential is a risk factor for venous thrombosisTon Lisman, Frits R. Rosendaal, Philip G. de Groot et al.|Blood|2004Cited by 281
Lupus anticoagulants and the risk of a first episode of deep venous thrombosisPhilip G. de Groot, Frits R. Rosendaal, Bianca C.H. Lutters et al.|Journal of Thrombosis and Haemostasis|2005Cited by 204